Arnaud Autret

Arnaud joined Illumina Ventures in 2022 as a Principal and Head of European Operations. Based in Amsterdam, Arnaud brings 15 years of experience in life science R&D and venture investment in the biopharmaceutical industry.

Before joining Illumina Ventures, Arnaud was an investment director for the biotechnology team of M Ventures, the corporate investment arm of Merck KGaA, based in Amsterdam. There he was instrumental in the investment in Scipio Bioscience, Pictor Labs and Nanosyrinx, among other companies. Arnaud started his investment career in Paris at Seventure Partners, where he invested in life sciences companies including Microbiome and Digital Health. Before joining Seventure, Arnaud was a senior financial auditor at KPMG in the healthcare business unit based in Paris.

Arnaud earned his Ph.D. in Immunology from the Pasteur Institute in Paris and continued his scientific career with post-doctoral work in Oncology at the Trinity College, Dublin. He gained his MSc in Finance from ESCP Europe, Paris.